DNTH Dianthus Therapeutics PE ratio, current and historical analysis
The P/E ratio for Dianthus Therapeutics stock stands at 2.83 as of Nov 21, 2024. The calculation is based on the latest EPS of $7.16 and the stock price of $20.27 per share.
DNTH PE ratio history
Dianthus Therapeutics PE ratio by year
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
DNTH average PE ratio chart
DNTH PE vs peers
DNTH's PE ratio is below its peer stock ORMP.
| Stock name | PE ratio | Market cap |
|---|---|---|
| DNTH Dianthus Therapeutics Inc | 2.83 | $599.93M |
| ORMP Oramed Pharmaceuticals Inc | 21 | $93.12M |
| OLMA Olema Pharmaceuticals Inc | N/A | $450.93M |
| OMER Omeros Corp | N/A | $447.95M |
| OMGA Omega Therapeutics Inc | N/A | $42.96M |
| ONCT Oncternal Therapeutics Inc | N/A | $3.43M |
| ONVO Organovo Holdings Inc | N/A | $5.38M |
| ORIC Oric Pharmaceuticals Inc | N/A | $643.57M |
Frequently asked questions
What is Dianthus Therapeutics's PE ratio?
The price to earnings ratio for DNTH stock as of Nov 21, 2024, stands at 2.83.
Why is Dianthus Therapeutics's PE ratio so low?
DNTH's PE ratio of 2.83 is considered low because the company's stock price is trading at a lower multiple of earnings.
How is DNTH's PE ratio calculated (Dianthus Therapeutics PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Nov 21, 2024), Dianthus Therapeutics's share price is $20.27. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $7.16. Therefore, Dianthus Therapeutics's price to earnings ratio for today is 2.83. PE RATIO(2.83) = STOCK PRICE($20.27) / TTM EPS($7.16)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.